Company Press Release

Sponsors Are Guaranteed to Receive Precise, Conclusive Thorough QT Results or Pay Nothing

Many years before the FDA offered its eSource Guidance in September 2013, Sirion Therapeutics launched its first two pivotal Phase III studies using entirely electronic source data collection.

TransCelerate BioPharma announced two new members, Merck & Co. Inc., and Novo Nordisk.

Forty-three percent of pharma and life sciences execs now support FDA evaluating drugs based on both clinical and economic effectiveness

The Food and Drug Administration's Oversight of Clinical Trials